MGAM
ABBV icon

McGowan Group Asset Management’s AbbVie ABBV Stock Holding History

McGowan Group Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76,128
Closed -$15M – 125
2024
Q3 		$15M Sell
76,128
-31,668
-29% -$5.91M 1.98% 16
2024
Q2 		$18.5M Buy
107,796
+323
+0.3% +$53.5K 2.57% 15
2024
Q1 		$19.6M Sell
107,473
-708
-0.7% -$122K 2.82% 15
2023
Q4 		$16.8M Sell
108,181
-1,969
-2% -$287K 2.69% 15
2023
Q3 		$16.4M Sell
110,150
-520
-0.5% -$76.3K 2.59% 14
2023
Q2 		$14.9M Sell
110,670
-22,179
-17% -$3.25M 2.32% 14
2023
Q1 		$21.2M Sell
132,849
-2,136
-2% -$327K 3.36% 7
2022
Q4 		$21.8M Buy
134,985
+1,069
+0.8% +$164K 3.47% 7
2022
Q3 		$18M Buy
133,916
+1,859
+1% +$267K 3.12% 9
2022
Q2 		$20.2M Buy
132,057
+14,400
+12% +$2.2M 3.39% 8
2022
Q1 		$19.1M Buy
117,657
+287
+0.2% +$41.7K 2.93% 8
2021
Q4 		$15.9M Buy
117,370
+2,463
+2% +$291K 2.79% 11
2021
Q3 		$12.4M Buy
114,907
+2,538
+2% +$290K 2.11% 16
2021
Q2 		$12.7M Buy
112,369
+1,623
+1% +$183K 1.99% 16
2021
Q1 		$12M Sell
110,746
-216
-0.2% -$23.1K 1.96% 17
2020
Q4 		$11.9M Buy
110,962
+6,227
+6% +$598K 2.03% 14
2020
Q3 		$9.17M Buy
104,735
+1,523
+1% +$143K 1.74% 18
2020
Q2 		$10.1M Buy
103,212
+100,380
+3,544% +$8.84M 1.89% 16
2020
Q1 		$216K Hold
2,832
– – 0.05% 77
2019
Q4 		$251K Sell
2,832
-80
-3% -$6.64K 0.04% 81
2019
Q3 		$220K Sell
2,912
-199
-6% -$13.6K 0.04% 87
2019
Q2 		$226K Sell
3,111
-33
-1% -$2.59K 0.04% 99
2019
Q1 		$253K Buy
3,144
+1
+0% +$82 0.04% 91
2018
Q4 		$290K Buy
3,143
+1
+0% +$88 0.05% 84
2018
Q3 		$297K Buy
3,142
+1
+0% +$95 0.05% 90
2018
Q2 		$291K Buy
3,141
+75
+2% +$7.33K 0.05% 88
2018
Q1 		$290K Buy
3,066
+200
+7% +$22K 0.05% 88
2017
Q4 		$277K Buy
2,866
+400
+16% +$37.7K 0.04% 87
2017
Q3 		$219K Buy
+2,466
New +$188K 0.04% 83

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

McGowan Group Asset Management's ABBV Position: Q4 2024 in Review

McGowan Group Asset Management sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 76,128 shares — an estimated $15M sold.

McGowan Group Asset Management first reported a position in ABBV in Q3 2017 and held it in 29 quarters. The position peaked at $21.8M in Q4 2022. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • McGowan Group Asset Management reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • McGowan Group Asset Management sold 76,128 AbbVie shares in Q4 2024, an estimated $15M.
  • McGowan Group Asset Management first reported a position in AbbVie in Q3 2017 and held it in 29 quarters.
  • McGowan Group Asset Management's AbbVie position peaked at $21.8M in Q4 2022.
  • 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on McGowan Group Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.